{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:22:10Z","timestamp":1780579330912,"version":"3.54.1"},"reference-count":87,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2018,12,29]],"date-time":"2018-12-29T00:00:00Z","timestamp":1546041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"San Matteo Hospital Foundation","award":["Not available"],"award-info":[{"award-number":["Not available"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Small bowel carcinomas (SBC) are uncommon neoplasms, whose predisposing conditions include hereditary syndromes and immune-mediated intestinal disorders including coeliac disease (CD) and Crohn\u2019s disease (CrD). Although both CD-associated SBC (CD-SBC) and CrD-associated SBC (CrD-SBC) arise from an inflammatory background, they differ substantially in tumour cell phenotype, frequency of microsatellite instability and nuclear \u03b2-catenin expression, as well as in prognosis. For these patients, high tumour-infiltrating lymphocyte density and glandular\/medullary histotype represent independent positive prognostic factors. Dysplasia adjacent to SBC is rare and characterized by intestinal phenotype and nuclear \u03b2-catenin in CD, while it is frequent and typified by gastro-pancreatobiliary marker expression and preserved membranous \u03b2-catenin in CrD. Recent evidence suggests that Epstein-Barr virus-positive dysplasia and SBC, albeit exceptional, do exist and are associated with CrD. In this review, we summarize the novel pathological and molecular insights of clinical and therapeutic interest to guide the care of CD-SBC and CrD-SBC.<\/jats:p>","DOI":"10.3390\/cancers11010031","type":"journal-article","created":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T07:22:30Z","timestamp":1546240950000},"page":"31","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Small Bowel Carcinomas Associated with Immune-Mediated Intestinal Disorders: The Current Knowledge"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7164-2439","authenticated-orcid":false,"given":"Paolo","family":"Giuffrida","sequence":"first","affiliation":[{"name":"First Department of Internal Medicine, University of Pavia and Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Vanoli","sequence":"additional","affiliation":[{"name":"Anatomic Pathology Unit, Department of Molecular Medicine, University of Pavia and Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Arpa","sequence":"additional","affiliation":[{"name":"Anatomic Pathology Unit, Department of Molecular Medicine, University of Pavia and Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Bonometti","sequence":"additional","affiliation":[{"name":"Anatomic Pathology Unit, Department of Molecular Medicine, University of Pavia and Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ombretta","family":"Luinetti","sequence":"additional","affiliation":[{"name":"Anatomic Pathology Unit, Department of Molecular Medicine, University of Pavia and Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Solcia","sequence":"additional","affiliation":[{"name":"Anatomic Pathology Unit, Department of Molecular Medicine, University of Pavia and Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gino Roberto","family":"Corazza","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, University of Pavia and Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Paulli","sequence":"additional","affiliation":[{"name":"Anatomic Pathology Unit, Department of Molecular Medicine, University of Pavia and Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Di Sabatino","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, University of Pavia and Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,12,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/nrclinonc.2013.132","article-title":"Small bowel adenocarcinomas\u2014Existing evidence and evolving paradigms","volume":"10","author":"Raghav","year":"2013","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/ecco-jcc\/jjx031","article-title":"Small Bowel Carcinomas in Coeliac or Crohn\u2019s Disease: Clinico-pathological, Molecular, and Prognostic Features. A Study from the Small Bowel Cancer Italian Consortium","volume":"11","author":"Vanoli","year":"2017","journal-title":"J. Crohns Colitis"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.autrev.2015.08.004","article-title":"New insights into immune mechanisms underlying autoimmune diseases of the gastrointestinal tract","volume":"14","author":"Lenti","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0140-6736(09)60254-3","article-title":"Coeliac disease","volume":"373","author":"Corazza","year":"2009","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"7073","DOI":"10.1158\/0008-5472.CAN-04-1096","article-title":"The role of defective mismatch repair in small bowel adenocarcinoma in celiac disease","volume":"64","author":"Potter","year":"2004","journal-title":"Cancer Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1158\/1078-0432.CCR-09-1773","article-title":"High-resolution array comparative genomic hybridization in sporadic and celiac disease-related small bowel adenocarcinomas","volume":"16","author":"Diosdado","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1038\/modpathol.2017.40","article-title":"Small bowel carcinomas in celiac or Crohn\u2019s disease: Distinctive histophenotypic, molecular and histogenetic patterns","volume":"30","author":"Vanoli","year":"2017","journal-title":"Mod. Pathol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1097\/MIB.0000000000000112","article-title":"Small bowel adenocarcinomas complicating Crohn\u2019s disease are associated with dysplasia: A pathological and molecular study","volume":"20","author":"Svrcek","year":"2014","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10620-017-4892-4","article-title":"Old and New Lymphocyte Players in Inflammatory Bowel Disease","volume":"63","author":"Giuffrida","year":"2018","journal-title":"Dig. Dis. Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00428-017-2125-z","article-title":"Small bowel adenocarcinoma complicating Crohn\u2019s disease: A single-centre experience emphasizing the importance of screening for dysplasia","volume":"471","author":"Grolleau","year":"2017","journal-title":"Virchows Arch."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0016-5085(97)70087-8","article-title":"Genetic alterations in sporadic and Crohn\u2019s-associated adenocarcinomas of the small intestine","volume":"113","author":"Rashid","year":"1997","journal-title":"Gastroenterology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1016\/j.cgh.2017.06.051","article-title":"Inflammatory Bowel Disease and Small Bowel Cancer Risk, Clinical Characteristics, and Histopathology: A Population-Based Study","volume":"15","author":"Bojesen","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/qjmed\/hcg058","article-title":"Primary small-bowel malignancy in the UK and its association with coeliac disease","volume":"96","author":"Howdle","year":"2003","journal-title":"QJM"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"320","DOI":"10.4065\/72.4.320","article-title":"Evidence against flat dysplasia as a regional field defect in small bowel adenocarcinoma associated with celiac sprue","volume":"72","author":"Bruno","year":"1997","journal-title":"Mayo Clin. Proc."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/BF02238592","article-title":"Adenocarcinoma complicating Crohn\u2019s disease","volume":"36","author":"Michelassi","year":"1993","journal-title":"Dis. Colon Rectum"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/00000478-199906000-00003","article-title":"Intestinal adenocarcinoma in Crohn\u2019s disease: A report of 30 cases with a focus on coexisting dysplasia","volume":"23","author":"Sigel","year":"1999","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/01.mib.0000179211.03650.b6","article-title":"Small bowel adenocarcinoma in patients with Crohn\u2019s disease compared with small bowel adenocarcinoma de novo","volume":"11","author":"Bouvier","year":"2005","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1111\/j.1572-0241.2008.01847.x","article-title":"Risk factors associated with small bowel adenocarcinoma in Crohn\u2019s disease: A case-control study","volume":"103","author":"Piton","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s11605-011-1441-x","article-title":"Small bowel adenocarcinoma in Crohn\u2019s disease","volume":"15","author":"Widmar","year":"2011","journal-title":"J. Gastrointest. Surg."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.humpath.2013.09.014","article-title":"Crohn enteritis-associated small bowel adenocarcinomas exhibit gastric differentiation","volume":"45","author":"Whitcomb","year":"2014","journal-title":"Hum. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1007\/s00261-014-0144-7","article-title":"Clinical characteristics and imaging features of small bowel adenocarcinomas in Crohn\u2019s disease","volume":"40","author":"Weber","year":"2015","journal-title":"Abdom. Imaging"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/codi.13531","article-title":"Prognosis of small bowel adenocarcinoma in Crohn\u2019s disease compares favourably with de novo small bowel adenocarcinoma","volume":"19","author":"Wieghard","year":"2017","journal-title":"Colorectal. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/modpathol.2010.223","article-title":"Genetics and epigenetics of small bowel adenocarcinoma: The interactions of CIN, MSI, and CIMP","volume":"24","author":"Warth","year":"2011","journal-title":"Mod. Pathol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/sj.bjc.6605449","article-title":"Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine","volume":"102","author":"Overman","year":"2010","journal-title":"Br. J. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/his.13133","article-title":"Small bowel Epstein-Barr virus-positive lympho-epithelioma-like carcinoma in Crohn\u2019s disease","volume":"70","author":"Vanoli","year":"2017","journal-title":"Histopathology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00428-017-2209-9","article-title":"Epstein-Barr virus-positive ileal carcinomas associated with Crohn\u2019s disease","volume":"471","author":"Vanoli","year":"2017","journal-title":"Virchows Arch."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/mc.20163","article-title":"No association of primary adenocarcinomas of the small bowel with Epstein-Barr virus infection","volume":"45","author":"Langner","year":"2006","journal-title":"Mol. Carcinog."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0278-6915(00)00136-8","article-title":"Anatomical and physiological parameters affecting gastrointestinal absorption in humans and rats","volume":"39","author":"DeSesso","year":"2001","journal-title":"Food Chem. Toxicol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.dld.2013.04.013","article-title":"Small bowel adenocarcinoma: Epidemiology, risk factors, diagnosis and treatment","volume":"46","author":"Aparicio","year":"2014","journal-title":"Dig. Liver Dis."},{"key":"ref_30","first-page":"1364","article-title":"Management of small bowel adenocarcinoma","volume":"16","author":"Kummar","year":"2002","journal-title":"Oncology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/SLA.0b013e31818e4641","article-title":"Small bowel cancer in the United States: Changes in epidemiology, treatment, and survival over the last 20 years","volume":"249","author":"Bilimoria","year":"2009","journal-title":"Ann. Surg."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.ejca.2011.10.038","article-title":"Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995\u20132002","volume":"48","author":"Faivre","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e1612","DOI":"10.1097\/MD.0000000000001612","article-title":"Association Between Coeliac Disease and Risk of Any Malignancy and Gastrointestinal Malignancy: A Meta-Analysis","volume":"94","author":"Han","year":"2015","journal-title":"Medicine"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1365-2036.2006.02854.x","article-title":"Meta-analysis: Colorectal and small bowel cancer risk in patients with Crohn\u2019s disease","volume":"23","author":"Canavan","year":"2006","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1007\/s10620-007-9952-8","article-title":"Effect of a gluten-free diet on the risk of enteropathy-associated T-cell lymphoma in celiac disease","volume":"53","author":"Silano","year":"2008","journal-title":"Dig. Dis. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cgh.2011.06.029","article-title":"Low risk of gastrointestinal cancer among patients with celiac disease, inflammation, or latent celiac disease","volume":"10","author":"Granath","year":"2012","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.cgh.2011.09.028","article-title":"Gastrointestinal cancer in celiac disease: \u201cThe first days are the hardest days, don\u2019t you worry anymore?\u201d","volume":"10","author":"Mukherjee","year":"2012","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Silano, M., Volta, U., Mecchia, A.M., Dess\u00ec, M., Di Benedetto, R., De Vincenzi, M., and Collaborating Centers of the Italian Registry of the Complications of Coeliac Disease (2007). Delayed diagnosis of coeliac disease increases cancer risk. BMC Gastroenterol., 7.","DOI":"10.1186\/1471-230X-7-8"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1182\/blood-2011-10-385559","article-title":"How I treat enteropathy-associated T-cell lymphoma","volume":"119","author":"Biagi","year":"2012","journal-title":"Blood"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/ecco-jcc\/jjx041","article-title":"The Time Course of Diagnostic Delay in Inflammatory Bowel Disease Over the Last Sixty Years: An Italian Multicentre Study","volume":"11","author":"Cantoro","year":"2017","journal-title":"J. Crohns Colitis"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"11486","DOI":"10.3748\/wjg.v20.i33.11486","article-title":"Small bowel adenocarcinoma and Crohn\u2019s disease: Any further ahead than 50 years ago?","volume":"20","author":"Cahill","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/BF01296557","article-title":"Risk factors for small bowel cancer in Crohn\u2019s disease","volume":"37","author":"Lashner","year":"1992","journal-title":"Dig. Dis. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00054725-200401000-00005","article-title":"Small intestinal adenocarcinoma in Crohn\u2019s disease: A case-control study","volume":"10","author":"Solem","year":"2004","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.annepidem.2008.10.004","article-title":"The epidemiology and pathogenesis of neoplasia in the small intestine","volume":"19","author":"Schottenfeld","year":"2009","journal-title":"Ann. Epidemiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/DCR.0b013e31826b9d0a","article-title":"Racial and ethnic variation in the incidence of small-bowel cancer subtypes in the United States, 1995\u20132008","volume":"56","author":"Goodman","year":"2013","journal-title":"Dis. Colon Rectum"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/his.12908","article-title":"Medullary carcinoma of the small bowel","volume":"69","author":"Brcic","year":"2016","journal-title":"Histopathology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/modpathol.2016.95","article-title":"PD-L1 expression in colorectal cancer is associated with microsatellite instability, BRAF mutation, medullary morphology and cytotoxic tumor-infiltrating lymphocytes","volume":"29","author":"Rosenbaum","year":"2016","journal-title":"Mod. Pathol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"De Rosa, S., Sahnane, N., Tibiletti, M.G., Magnoli, F., Vanoli, A., Sessa, F., and Chiaravalli, A.M. (2018). EBV\u207a and MSI Gastric Cancers Harbor High PD-L1\/PD-1 Expression and High CD8\u207a Intratumoral Lymphocytes. Cancers, 10.","DOI":"10.3390\/cancers10040102"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/AJCP\/AQX070","article-title":"Could the PD-1 Pathway Be a Potential Target for Treating Small Intestinal Adenocarcinoma?","volume":"148","author":"Thota","year":"2017","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1001\/jamaoncol.2017.1051","article-title":"Genomic Profiling of Small-Bowel Adenocarcinoma","volume":"3","author":"Schrock","year":"2017","journal-title":"JAMA Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1038\/bjc.2013.677","article-title":"Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study","volume":"109","author":"Aparicio","year":"2013","journal-title":"Br. J. Cancer"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1053\/j.gastro.2016.04.001","article-title":"Genomic Alterations Observed in Colitis-Associated Cancers Are Distinct from Those Found in Sporadic Colorectal Cancers and Vary by Type of Inflammatory Bowel Disease","volume":"151","author":"Yaeger","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1002\/(SICI)1097-0142(19970501)79:9<1804::AID-CNCR24>3.0.CO;2-0","article-title":"The presence of K-12 ras mutations in duodenal adenocarcinomas and the absence of ras mutations in other small bowel adenocarcinomas and carcinoid tumors","volume":"79","author":"Younes","year":"1997","journal-title":"Cancer"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1080\/00365520410005847","article-title":"Mutational activation of the RAS-RAF-MAPK and the Wnt pathway in small intestinal adenocarcinomas","volume":"39","author":"Helmchen","year":"2004","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1309\/AJCPS54RTFCTHGWX","article-title":"Combined loss of E-cadherin and aberrant \u03b2-catenin protein expression correlates with a poor prognosis for small intestinal adenocarcinomas","volume":"139","author":"Lee","year":"2013","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.molcel.2014.08.010","article-title":"The BRAF oncoprotein functions through the transcriptional repressor MAFG to mediate the CpG Island Methylator phenotype","volume":"55","author":"Fang","year":"2014","journal-title":"Mol. Cell."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e02313","DOI":"10.7554\/eLife.02313","article-title":"A KRAS-directed transcriptional silencing pathway that mediates the CpG island methylator phenotype","volume":"3","author":"Serra","year":"2014","journal-title":"Elife"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.ejca.2014.04.007","article-title":"ERBB2 gene as a potential therapeutic target in small bowel adenocarcinoma","volume":"50","author":"Laforest","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1136\/gut.52.8.1211","article-title":"Small bowel neoplasia in coeliac disease","volume":"52","author":"Rampertab","year":"2003","journal-title":"Gut"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/1097-0142(19810801)48:3<799::AID-CNCR2820480324>3.0.CO;2-Q","article-title":"Adenomas of the small intestine: A clinicopathologic review of 51 cases and a study of their relationship to carcinoma","volume":"48","author":"Perzin","year":"1981","journal-title":"Cancer"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.bpg.2013.03.013","article-title":"Advanced precancerous lesions in the small bowel mucosa","volume":"27","author":"Genta","year":"2013","journal-title":"Best. Pract. Res. Clin. Gastroenterol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Senger, S., Sapone, A., Fiorentino, M.R., Mazzarella, G., Lauwers, G.Y., and Fasano, A. (2015). Celiac Disease Histopathology Recapitulates Hedgehog Downregulation, Consistent with wound Healing Processes Activation. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0144634"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/ecco-jcc\/jjw123","article-title":"Endoscopic Detection of Small Bowel Dysplasia and Adenocarcinoma in Crohn\u2019s Disease: A Prospective Cohort-Study in High-Risk Patients","volume":"11","author":"Simon","year":"2017","journal-title":"J. Crohns Colitis"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12026-015-8737-y","article-title":"Differential cellular localization of Epstein-Barr virus and human cytomegalovirus in the colonic mucosa of patients with active or quiescent inflammatory bowel disease","volume":"64","author":"Ciccocioppo","year":"2016","journal-title":"Immunol. Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fonc.2015.00073","article-title":"Epstein-barr virus in gastroesophageal adenocarcinomas\u2014Single center experiences in the context of current literature","volume":"5","author":"Genitsch","year":"2015","journal-title":"Front. Oncol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/MCG.0000000000000424","article-title":"Celiac Disease and Double-Balloon Enteroscopy: What Can we Achieve? The Experience of 2 European Tertiary Referral Centers","volume":"50","author":"Tomba","year":"2016","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/ecco-jcc\/jjw055","article-title":"European Crohn\u2019s and Colitis Organisation Topical Review on Prediction, Diagnosis and Management of Fibrostenosing Crohn\u2019s Disease","volume":"10","author":"Rieder","year":"2016","journal-title":"J. Crohns Colitis"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Bergamaschi, G., Di Sabatino, A., and Corazza, G.R. (2018). Pathogenesis, diagnosis and treatment of anaemia in immune-mediated gastrointestinal disorders. Br. J. Haematol.","DOI":"10.1111\/bjh.15254"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.crohns.2010.10.008","article-title":"Small bowel carcinoma mimicking a relapse of Crohn\u2019s disease: A case series","volume":"5","author":"Baars","year":"2011","journal-title":"J. Crohns Colitis"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/1097-0142(19850201)55:3<516::AID-CNCR2820550308>3.0.CO;2-K","article-title":"Small intestinal adenocarcinoma complicating regional enteritis","volume":"55","author":"Collier","year":"1985","journal-title":"Cancer"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1245\/s10434-011-2173-6","article-title":"A population-based comparison of adenocarcinoma of the large and small intestine: Insights into a rare disease","volume":"19","author":"Overman","year":"2012","journal-title":"Ann. Surg. Oncol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.amjsurg.2009.05.037","article-title":"A single-institution experience with 491 cases of small bowel adenocarcinoma","volume":"199","author":"Halfdanarson","year":"2010","journal-title":"Am. J. Surg."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.1002\/cncr.25324","article-title":"Prognostic value of lymph node evaluation in small bowel adenocarcinoma: Analysis of the surveillance, epidemiology, and end results database","volume":"116","author":"Overman","year":"2010","journal-title":"Cancer"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/cncr.20404","article-title":"Adenocarcinoma of the small bowel: Presentation, prognostic factors, and outcome of 217 patients","volume":"101","author":"Dabaja","year":"2004","journal-title":"Cancer"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.dld.2017.09.123","article-title":"Small bowel adenocarcinoma: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO)","volume":"50","author":"Locher","year":"2018","journal-title":"Dig. Liver Dis."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/sj.bjc.6605898","article-title":"Cetuximab in small bowel adenocarcinoma: A new friend?","volume":"103","author":"Santini","year":"2010","journal-title":"Br. J. Cancer"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e9672","DOI":"10.1097\/MD.0000000000009672","article-title":"Anti epidermal growth factor receptor therapy in small bowel adenocarcinoma: Case report and literature review","volume":"97","author":"Falcone","year":"2018","journal-title":"Medicine"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"277-e26","DOI":"10.1634\/theoncologist.2017-0568","article-title":"Phase II Study of Panitumumab in RAS Wild-Type Metastatic Adenocarcinoma of Small Bowel or Ampulla of Vater","volume":"23","author":"Gulhati","year":"2018","journal-title":"Oncologist"},{"key":"ref_79","first-page":"22","article-title":"Right-sided vs left-sided colorectal cancer","volume":"15","author":"Venook","year":"2017","journal-title":"Clin. Adv. Hematol. Oncol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"983","DOI":"10.6004\/jnccn.2017.0140","article-title":"Neoadjuvant Treatment with Trastuzumab and FOLFOX Induces a Complete Pathologic Response in a Metastatic ERBB2 (HER2)-Amplified Duodenal Cancer","volume":"15","author":"Hamad","year":"2017","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"ref_81","unstructured":"US National Library of Medicine (2018, November 18). ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03000179?term=avelumab&cond=Small+Bowel+Carcinoma&rank=1."},{"key":"ref_82","unstructured":"US National Library of Medicine (2018, November 18). ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03108131?term=atezolizumab&cond=Small+Bowel+Cancer&rank=1."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 Blockade in Tumors with Mismatch-Repair Deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_84","unstructured":"US National Library of Medicine (2018, November 18). ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02949219?term=pembrolizumab&cond=Small+Bowel+Cancer&rank=1."},{"key":"ref_85","unstructured":"US National Library of Medicine (2018, November 18). ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03095781?term=pembrolizumab&cond=Small+Bowel+Cancer&rank=2."},{"key":"ref_86","unstructured":"US National Library of Medicine (2018, November 18). ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02834013?term=ipilimumab&recrs=ab&cond=Small+Bowel+Adenocarcinoma&rank=1."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.aan6733","article-title":"Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade","volume":"357","author":"Le","year":"2017","journal-title":"Science"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/11\/1\/31\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:36:39Z","timestamp":1760196999000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/11\/1\/31"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,29]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1]]}},"alternative-id":["cancers11010031"],"URL":"https:\/\/doi.org\/10.3390\/cancers11010031","relation":{"has-preprint":[{"id-type":"doi","id":"10.20944\/preprints201811.0511.v1","asserted-by":"object"}]},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,29]]}}}